Annual D&A:
$2.29M+$1.09M(+91.86%)Summary
- As of today, INBX annual D&A is $2.29 million, with the most recent change of +$1.09 million (+91.86%) on December 31, 2024.
- During the last 3 years, INBX annual D&A has risen by +$1.09 million (+91.21%).
- INBX annual D&A is now at all-time high.
Performance
INBX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$583.00K-$78.00K(-11.80%)Summary
- As of today, INBX quarterly D&A is $583.00 thousand, with the most recent change of -$78.00 thousand (-11.80%) on September 30, 2025.
- Over the past year, INBX quarterly D&A has dropped by -$177.00 thousand (-23.29%).
- INBX quarterly D&A is now -23.69% below its all-time high of $764.00 thousand, reached on March 31, 2019.
Performance
INBX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.61M-$177.00K(-6.36%)Summary
- As of today, INBX TTM D&A is $2.61 million, with the most recent change of -$177.00 thousand (-6.36%) on September 30, 2025.
- Over the past year, INBX TTM D&A has increased by +$1.01 million (+63.41%).
- INBX TTM D&A is now -6.36% below its all-time high of $2.79 million, reached on June 30, 2025.
Performance
INBX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
INBX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +91.9% | -23.3% | +63.4% |
| 3Y3 Years | +91.2% | +88.7% | +112.0% |
| 5Y5 Years | +96.5% | +134.1% | +163.2% |
INBX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +91.9% | -23.3% | +98.3% | -6.4% | +298.8% |
| 5Y | 5-Year | at high | +124.2% | -23.3% | +134.1% | -6.4% | +298.8% |
| All-Time | All-Time | at high | +472.7% | -23.7% | +261.9% | -6.4% | +1627.2% |
INBX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $583.00K(-11.8%) | $2.61M(-6.4%) |
| Jun 2025 | - | $661.00K(-2.1%) | $2.79M(+7.1%) |
| Mar 2025 | - | $675.00K(-2.0%) | $2.60M(+13.8%) |
| Dec 2024 | $2.29M(+91.9%) | $689.00K(-9.3%) | $2.29M(+43.2%) |
| Sep 2024 | - | $760.00K(+59.7%) | $1.60M(+90.9%) |
| Jun 2024 | - | $476.00K(+32.2%) | $836.00K(+27.8%) |
| Mar 2024 | - | $360.00K(+22.4%) | $654.00K(-45.5%) |
| Dec 2023 | $1.19M(-2.8%) | - | - |
| Jun 2023 | - | $294.00K(-0.3%) | $1.20M(-1.1%) |
| Mar 2023 | - | $295.00K(-2.3%) | $1.21M(-1.0%) |
| Dec 2022 | $1.23M(+2.5%) | $302.00K(-2.3%) | $1.23M(-0.4%) |
| Sep 2022 | - | $309.00K(+0.7%) | $1.23M(+0.8%) |
| Jun 2022 | - | $307.00K(0.0%) | $1.22M(+0.7%) |
| Mar 2022 | - | $307.00K(0.0%) | $1.21M(+1.3%) |
| Dec 2021 | $1.20M | $307.00K(+2.7%) | $1.20M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $299.00K(+0.3%) | $1.15M(+4.5%) |
| Jun 2021 | - | $298.00K(+2.4%) | $1.10M(+4.6%) |
| Mar 2021 | - | $291.00K(+9.8%) | $1.05M(+3.4%) |
| Dec 2020 | $1.02M(-12.4%) | $265.00K(+6.4%) | $1.02M(+2.8%) |
| Sep 2020 | - | $249.00K(0.0%) | $991.00K(-21.6%) |
| Jun 2020 | - | $249.00K(-2.7%) | $1.26M(+93.0%) |
| Mar 2020 | - | $256.00K(+8.0%) | $655.00K(-43.7%) |
| Dec 2019 | $1.16M(+72.0%) | $237.00K(-54.6%) | $1.16M(+25.6%) |
| Sep 2019 | - | $522.00K(+245.0%) | $926.00K(+129.2%) |
| Jun 2019 | - | -$360.00K(-147.1%) | $404.00K(-56.5%) |
| Mar 2019 | - | $764.00K(+363.0%) | $929.00K(+194.0%) |
| Dec 2018 | $676.00K(+69.4%) | - | - |
| Jun 2018 | - | $165.00K(+9.3%) | $316.00K(+109.3%) |
| Mar 2018 | - | $151.00K | $151.00K |
| Dec 2017 | $399.00K | - | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual D&A?
- What is the all-time high annual D&A for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual D&A year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly D&A year-on-year change?
- What is Inhibrx Biosciences, Inc. TTM D&A?
- What is the all-time high TTM D&A for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. TTM D&A year-on-year change?
What is Inhibrx Biosciences, Inc. annual D&A?
The current annual D&A of INBX is $2.29M
What is the all-time high annual D&A for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual D&A is $2.29M
What is Inhibrx Biosciences, Inc. annual D&A year-on-year change?
Over the past year, INBX annual D&A has changed by +$1.09M (+91.86%)
What is Inhibrx Biosciences, Inc. quarterly D&A?
The current quarterly D&A of INBX is $583.00K
What is the all-time high quarterly D&A for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly D&A is $764.00K
What is Inhibrx Biosciences, Inc. quarterly D&A year-on-year change?
Over the past year, INBX quarterly D&A has changed by -$177.00K (-23.29%)
What is Inhibrx Biosciences, Inc. TTM D&A?
The current TTM D&A of INBX is $2.61M
What is the all-time high TTM D&A for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high TTM D&A is $2.79M
What is Inhibrx Biosciences, Inc. TTM D&A year-on-year change?
Over the past year, INBX TTM D&A has changed by +$1.01M (+63.41%)